Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder

Simone de Jong, Mateus Jose Abdalla Diniz, Andiara Saloma, Ary Gadelha, Marcos Santoro, Vanessa Ota, Cristiano Noto, Naomi R. Wray, Stephan Ripke, Manuel Mattheisen, Maciej Trzaskowski, Enda M. Byrne, Abdel Abdellaoui, Mark J. Adams, Esben Agerbo, Tracy Air, Till F. M. Andlauer, Silviu‐Alin Bacanu, Marie Bækvad‐Hansen, Aartjan T.f. Beekman, Tim B. Bigdeli, Elisabeth B. Binder, Douglas Blackwood, Julien Bryois, Henriette N. Buttenschøn, Jonas Bybjerg‐Grauholm, Na Cai, Enrique Castelao, Jane Christensen, Toni‐Kim Clarke, Jonathan R. I. Coleman, Lucía Colodro‐Conde, Baptiste Couvy‐Duchesne, Nick Craddock, Gregory E. Crawford, Gail Davies, Ian J. Deary, Franziska Degenhardt, Eske M. Derks, Neşe Direk, Conor V. Dolan, Erin C. Dunn, Thalia C. Eley, Valentina Escott‐Price, Farnush Farhadi Hassan Kiadeh, Hilary K. Finucane, Andreas J. Forstner, Josef Frank, Héléna A. Gaspar, Michael Gill, Fernando S. Goes, Scott D. Gordon, Jakob Grove, Christine Søholm Hansen, Thomas Folkmann Hansen, Stefan Herms, Ian B. Hickie, Per Hoffmann, Georg Homuth, Carsten Horn, Jouke‐Jan Hottenga, David M. Hougaard, Marcus Ising, Philip R. Jansen, Ian Jones, Lisa Jones, Eric Jorgenson, James A. Knowles, Isaac S. Kohane, Julia Kraft, Warren W. Kretzschmar, Jesper Krogh, Zoltán Kutalik, Yihan Li, Penelope A. Lind, Donald J. MacIntyre, Dean F. MacKinnon, Robert Maier, Wolfgang Maier, Jonathan Marchini, Hamdi Mbarek, Patrick J. McGrath, Peter McGuffin, Sarah E. Medland, Divya Mehta, Christel M. Middeldorp, Evelin Mihailov, Yuri Milaneschi, Lili Milani, Francis M. Mondimore, Grant W. Montgomery, Sara Mostafavi, Niamh Mullins, Matthias Nauck, Bernard Ng, Michel G. Nivard, Dale R. Nyholt, Högni Óskarsson, Michael J. Owen, Jodie N. PainterCommunications 2018 · DOI

Abstract

Psychiatric disorders are thought to have a complex genetic pathology consisting of an interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores (PRS) to also highlight patterns of common genetic risk. We analyze PRS for psychiatric disorders in a large pedigree (n ~ 260) in which 30% of family members suffer from major depressive disorder (MDD) or bipolar disorder (BPD). Studying patterns of assortative mating and anticipation, it appears increased polygenic risk is contributed by affected individuals who married into the family, resulting in an increasing genetic risk over generations. This may explain the observation of anticipation in mood disorders, whereby onset is earlier and the severity increases over the generations of a family. Joint analyses of rare and common variation may be a powerful way to understand the familial genetics of psychiatric disorders.

Introduction

Psychiatric genetics has traditionally been divided into two distinct methodologies: pedigree studies, which search for rare, high-impact mutations via linkage analysis, and large-scale population studies (GWAS), which identify common, low-impact variants. However, most psychiatric disorders are complex, likely resulting from the combined effects of both types of variation.

A persistent mystery in clinical psychiatry is anticipation—the observation that in certain families, a disorder manifests earlier and with greater severity in each subsequent generation. While biological mechanisms like trinucleotide repeat expansions explain this in other diseases, the cause in mood disorders remains elusive. This study investigates whether the accumulation of common genetic risk, measured via Polygenic Risk Scores (PRS), can explain these familial patterns.

Methods and Datasets

The researchers focused on the Brazilian Bipolar Family (BBF), a massive pedigree of approximately 260 individuals where 30% of members suffer from BPD or MDD. The final dataset for analysis included 243 individuals (197 family members and 46 "married-in" individuals) and a population control group of 57 healthy individuals from São Paulo, Brazil.

PRS for Schizophrenia (SCZ), BPD, and MDD were calculated using summary statistics from the Psychiatric Genomics Consortium (PGC). To account for the complex relatedness within the pedigree, the team utilized Linear Mixed Models (ASReml-R and LDAK) to fit an additive genetic relationship matrix as a random effect. Additionally, they integrated these results with previously identified rare risk variants to determine if common and rare risks were correlated.

Key Results

The "Married-In" Effect and Assortative Mating

A striking finding was the role of individuals who married into the family. Approximately 27% of these individuals had a psychiatric disorder, significantly higher than the 17% population prevalence. This indicates strong assortative mating, where individuals with a genetic predisposition for mood disorders are more likely to partner with one another.

PRS distributions across different parental affection categories. Note the higher scores in the "Married-in parent affected" group compared to the "No parents affected" group.

Offspring of an affected married-in parent showed significantly higher SCZ:PRS (p = 0.002) and BPD:PRS (p = 0.013) compared to those with no affected parents. Effectively, these individuals were "importing" additional common risk alleles into an already high-risk family.

Explaining Clinical Anticipation

This influx of risk alleles resulted in a statistically significant linear increase in SCZ:PRS across generations G3 to G6 (β = 0.131, p = 0.008). This generational accumulation of common risk provides a genomic explanation for clinical anticipation: as the "common risk load" increases, the threshold for disease onset is reached earlier in life.

Generational increase in standardized PRS for SCZ, MDD, and BPD across generations G3 to G6.

Independence of Risk Types

Interestingly, common polygenic risk and rare linkage-identified risk appeared to be independent. Carrying a previously identified rare risk allele did not significantly change an individual's PRS, suggesting these two types of genetic risk contribute to the disease through distinct pathways.

Discussion and Limitations

While the sample size (n ~ 260) is large for a pedigree, it remains relatively small for PRS analysis, which typically requires thousands of samples to achieve high power. This limited the ability to find direct correlations between PRS and age of onset within specific generations. Furthermore, potential ascertainment bias (recall bias in older generations) and the "unknown" status of younger members who may develop disorders later must be considered.

Despite these limitations, the study demonstrates that PRS can successfully discriminate between affected and unaffected members in a pedigree. It suggests that future psychiatric research should move toward joint analyses that combine rare variant discovery with polygenic risk to fully map the genetic architecture of mental illness.

Summary updated

Abstract

Psychiatric disorders are thought to have a complex genetic pathology consisting of interplay of common and rare variation. Traditionally, pedigrees are used to shed light on the latter only, while here we discuss the application of polygenic risk scores to also highlight patterns of common genetic risk. We analyze polygenic risk scores for psychiatric disorders in a large pedigree (<i>n</i> ~ 260) in which 30% of family members suffer from major depressive disorder or bipolar disorder. Studying patterns of assortative mating and anticipation, it appears increased polygenic risk is contributed by affected individuals who married into the family, resulting in an increasing genetic risk over generations. This may explain the observation of anticipation in mood disorders, whereby onset is earlier and the severity increases over the generations of a family. Joint analyses of rare and common variation may be a powerful way to understand the familial genetics of psychiatric disorders.
BibTeX
@inproceedings{jong2018applying,
  author = {Simone de Jong and Mateus Jose Abdalla Diniz and Andiara Saloma and Ary Gadelha and Marcos Santoro and Vanessa Ota and Cristiano Noto and Naomi R. Wray and Stephan Ripke and Manuel Mattheisen and Maciej Trzaskowski and Enda M. Byrne and Abdel Abdellaoui and Mark J. Adams and Esben Agerbo and Tracy Air and Till F. M. Andlauer and Silviu‐Alin Bacanu and Marie Bækvad‐Hansen and Aartjan T.F. Beekman and Tim B. Bigdeli and Elisabeth B. Binder and Douglas Blackwood and Julien Bryois and Henriette N. Buttenschøn and Jonas Bybjerg‐Grauholm and Na Cai and Enrique Castelao and Jane Christensen and Toni‐Kim Clarke and Jonathan R. I. Coleman and Lucía Colodro‐Conde and Baptiste Couvy‐Duchesne and Nick Craddock and Gregory E. Crawford and Gail Davies and Ian J. Deary and Franziska Degenhardt and Eske M. Derks and Neşe Direk and Conor V. Dolan and Erin C. Dunn and Thalia C. Eley and Valentina Escott‐Price and Farnush Farhadi Hassan Kiadeh and Hilary K. Finucane and Andreas J. Forstner and Josef Frank and Héléna A. Gaspar and Michael Gill and Fernando S. Goes and Scott D. Gordon and Jakob Grove and Christine Søholm Hansen and Thomas Folkmann Hansen and Stefan Herms and Ian B. Hickie and Per Hoffmann and Georg Homuth and Carsten Horn and Jouke‐Jan Hottenga and David M. Hougaard and Marcus Ising and Philip R. Jansen and Ian Jones and Lisa Jones and Eric Jorgenson and James A. Knowles and Isaac S. Kohane and Julia Kraft and Warren W. Kretzschmar and Jesper Krogh and Zoltán Kutalik and Yihan Li and Penelope A. Lind and Donald J. MacIntyre and Dean F. MacKinnon and Robert Maier and Wolfgang Maier and Jonathan Marchini and Hamdi Mbarek and Patrick J. McGrath and Peter McGuffin and Sarah E. Medland and Divya Mehta and Christel M. Middeldorp and Evelin Mihailov and Yuri Milaneschi and Lili Milani and Francis M. Mondimore and Grant W. Montgomery and Sara Mostafavi and Niamh Mullins and Matthias Nauck and Bernard Ng and Michel G. Nivard and Dale R. Nyholt and Högni Óskarsson and Michael J. Owen and Jodie N. Painter},
  title = {{Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder}},
  booktitle = {Communications},
  year = {2018},
  doi = {10.1038/s42003-018-0155-y},
}
Figure